FDA's Center for Biologics Evaluation and Research regulates the following products: allergenic extracts, monoclonal antibodies, biotech derived therapeutics, somatic cell and gene therapy, xenotransplantation, tissues, some devices, whole blood, blood components, blood derivatives, and vaccines.
FDA Office of Pharmaceutical Quality Initiatives & 2016 Priorities
Friday, 24 Jun 2016 12.06
Interdisciplinary Perspectives on Key Pharma Industry Trends
Thursday, 23 Jun 2016 15.06
Endless Opportunities to Expand Your Knowledge & Network
Wednesday, 22 Jun 2016 12.06